Deutsche Bank
PCRX icon

Deutsche Bank’s Pacira BioSciences PCRX Stock Holding History

Deutsche Bank’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-300
Closed -$11K – 5094
2017
Q3 		$11K Buy
+300
New +$12.1K ﹤0.01% 4659
2014
Q1 		– Sell
-130
Closed -$2K – 5736
2013
Q4 		$2K Hold
130
– – ﹤0.01% 5184
2013
Q3 		$1K Buy
+130
New +$4.74K ﹤0.01% 5428

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank's PCRX Position: Q2 2026 in Review

Deutsche Bank reduced its Pacira BioSciences (PCRX) stake by 0.15% in Q2 2026, selling an estimated $13.6K and leaving 391,101 shares worth $9.92M. The position accounts for ﹤0.01% of the portfolio, ranked #1068.

Deutsche Bank first reported a position in PCRX in Q2 2013 and has held it in 53 quarters since. The position peaked at $50.1M in Q1 2015. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Deutsche Bank held 391,101 shares of Pacira BioSciences worth $9.92M as of Q2 2026.
  • Deutsche Bank sold 576 Pacira BioSciences shares in Q2 2026, an estimated $13.6K.
  • Pacira BioSciences made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1068 holding.
  • Deutsche Bank first reported a position in Pacira BioSciences in Q2 2013 and has held it in 53 quarters since.
  • Deutsche Bank's Pacira BioSciences position peaked at $50.1M in Q1 2015.
  • 254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.